Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D levels are not linked to alopecia areata.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Lower vitamin D levels are linked to more severe alopecia areata.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Both treatments for alopecia areata showed similar modest effectiveness.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Red light therapy is safe and effectively increases hair growth in women with hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Women's hair grows faster and thicker than men's, but hair growth slows for both genders with pattern hair loss.

Finasteride works for hair loss by maintaining existing hair follicles, not reversing miniaturization.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

The research provides specific measurements for hair follicles that can improve hair transplant and regeneration techniques.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Minoxidil can help regrow hair in alopecia areata patients.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.